Insilicos Using $1.2M SBIR Grant for 400-Subject Study Investigating Cardiovascular Biomarkers
September 24, 2010
Insilicos Using $1.2M SBIR Grant for 400-Subject Study Investigating Cardiovascular Biomarkers
Building on the results of a 38-patient study published in July, the company hopes to develop its PreClue cardiovascular disease biomarker panel as a clinical diagnostic for either screening or treatment-planning purposes.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- FDA's 510(k) Action Plan Draws Praise, Criticism from Proteomics Diagnostics Community
February 4, 2011 / ProteoMonitor - Singulex Receives US Patent for Cardiovascular Biomarker Assay, Begins Planning FDA Submission
December 17, 2010 / ProteoMonitor - Hutch, Broad Teams Publish Comprehensive Methods for MS-Based Biomarker Discovery and Verification
July 29, 2011 / ProteoMonitor - Lung Cancer Study Highlights Current Limitations of MALDI Mass Spec
July 22, 2011 / ProteoMonitor - People In The News
July 1, 2011 / GenomeWeb Daily News